Abstract 4078: Tumors with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Research"
DOI: 10.1158/1538-7445.am2017-4078
Abstract: Approximately two hundred mutant BRAF alleles have been identified in human tumors. Physiologic activation of RAF isoforms requires RAS-dependent induction of their dimerization. Activating BRAF mutants cause ERK dependent feedback inhibition of RAS.GTP and are… read more here.
Keywords: braf mutants; class braf; mutants sensitive; braf ... See more keywords
Abstract 1651: NRX-0305: a pan-mutant BRAF degrader with broad preclinical efficacy, brain penetrance, and synergistic potential with MEKi across class 1/2/3 BRAF-mutant cancers
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-1651
Abstract: Mutations in BRAF, a key component of the mitogen-activated protein kinase (MAPK) pathway, drive constitutive pathway activation and oncogenic transformation and are commonly found in a variety of cancers including melanoma, NSCLC and CRC. BRAF… read more here.
Keywords: nrx 0305; braf; class braf; class ... See more keywords
Recognition of BRAF by CDC37 and Re-Evaluation of the Activation Mechanism for the Class 2 BRAF-L597R Mutant
Sign Up to like & getrecommendations! Published in 2022 at "Biomolecules"
DOI: 10.3390/biom12070905
Abstract: The kinome specific co-chaperone, CDC37, is responsible for delivering BRAF to the Hsp90 complex, where it is then translocated to the RAS complex at the plasma membrane for RAS mediated dimerization and subsequent activation. We… read more here.
Keywords: recognition; class braf; braf; cdc37 ... See more keywords